Indiana University Bloomington is a public research university in Bloomington, Indiana. It is the flagship campus of Indiana University and, with over 40,000 students, its largest campus.

During the past decade, Indiana University conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 5 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University" #1 sponsor was "Indiana University" with 17 trials, followed by "Albert Einstein College of Medicine" with 1 trials sponsored, "Bausch & Lomb Incorporated" with 1 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials sponsored and "Columbia University" with 1 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University" #1 collaborator was "Indiana University" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "University of California, San Diego" with 2 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University" are "Asthma" (3 trials), "Anxiety" (2 trials), "Basic Science" (2 trials), "Depression" (2 trials) and "Emotion Regulation" (2 trials). Many other conditions were trialed in "Indiana University" in a lesser frequency.

Most popular intervention types in "Indiana University" are "Other" (15 trials), "Behavioral" (8 trials), "Device" (7 trials), "Drug" (7 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Doing What Matters in Times of Stress: An Illustrated Guide" (2 trials), "5-Cog Paradigm (5-Cog battery coupled with clinical decision tool)" (1 trials), "Active Fish Oil + Montelukast Placebo" (1 trials), "Active Montelukast + Active Fish Oil" (1 trials) and "Active Montelukast + Fish Oil Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University" are 37 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 16 active trials in "Indiana University". 1 are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 21 completed trials in Indiana University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 24 trials that are defined as “Not Applicable".

Indiana University has several departments that took part in Clinical trials: "IU Department of Speech & Hearing Sciences" - 2 trials